Related Experiment Video
Updated: Aug 22, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Strategies for managing diabetic patients on peritoneal dialysis
1University of Alberta, Edmonton, Alberta, Canada. mkdg@ualberta.ca
Abstract:
Failure of the pancreatic beta cells to produce insulin or development of defective molecular signaling of insulin to the peripheral tissue cells (insulin resistance) induces persistent hyperglycemia and accumulation of fatty acids in the blood of patients with diabetes. Over time, those changes lead to microvascular and macrovascular damage in various target organs. In patients on peritoneal dialysis (PD), complications may accelerate with treatment using conventional glucose-containing solutions. Strategies for proper glycemic control in diabetic PD patients are therefore essential to prevent complications and to maintain a good quality of life. Dietary restrictions and weight control remain the foundation of the management approach for glycemic control. Further therapeutic actions include the stepwise addition of oral hypoglycemic agents and insulin, based on individual assessment of PD patients. Other strategies of immediate importance in reducing hyperglycemia are to use PD exchanges with new non glucose PD solutions (such as those with icodextrin or amino acids) in combination with fewer daily exchanges of low-glucose solutions. Combined, these approaches will sufficiently control hyperglycemia in diabetic PD patients. Research is in progress to develop therapeutic agents aimed at correcting various molecular defects of insulin signaling or at reducing protein kinase C activation induced by oxidative stresses in various tissue cells. Clinical experience with the use of such agents in diabetic PD patients is limited at present.
Insights
Diabetic patients on peritoneal dialysis (PD) require careful glycemic control to prevent complications. Utilizing non-glucose PD solutions and adjusting medications can effectively manage hyperglycemia in these patients.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus is characterized by insulin deficiency or resistance, leading to hyperglycemia and hyperlipidemia.
- Persistent hyperglycemia and dyslipidemia contribute to microvascular and macrovascular complications.
- Conventional glucose-based peritoneal dialysis (PD) solutions can exacerbate hyperglycemia in diabetic patients.
Purpose of the Study:
- To outline essential strategies for optimal glycemic control in diabetic patients undergoing PD.
- To highlight the importance of preventing complications and maintaining quality of life in this patient population.
Main Methods:
- Foundation of management includes dietary restrictions and weight control.
- Therapeutic escalation involves oral hypoglycemic agents and insulin, tailored to individual PD patients.
- Incorporation of non-glucose PD solutions (icodextrin, amino acids) with reduced low-glucose exchanges is crucial.
Main Results:
- Combined dietary, pharmacological, and PD fluid management strategies effectively control hyperglycemia in diabetic PD patients.
- The use of non-glucose PD solutions offers a significant advantage in managing blood glucose levels.
- Ongoing research aims to develop novel agents targeting insulin signaling defects and oxidative stress pathways.
Conclusions:
- A multifaceted approach combining lifestyle modifications, pharmacotherapy, and innovative PD solutions is vital for managing diabetic PD patients.
- Further research and clinical trials are needed to evaluate new therapeutic agents in this specific patient group.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis III: Nursing Management
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease III: Interprofessional Care
